Abstract
Purpose
This study aims to compare treatment response and adherence rate to positive airway pressure (PAP) in patients with opioid-related central sleep apnea (O-CSA) and idiopathic central sleep apnea (I-CSA).
Methods
We performed a retrospective chart over a 5-year period performed at a VA sleep center. Continuous PAP (CPAP) was prescribed initially for all participants. For those nonresponders (apnea hypopnea index (AHI) of >10/h), bi-level PAP (BiPAP) or adaptive servoventilation (ASV) was instituted upon provider’s discretion. Adherence to therapy was checked with the built-in meter.
Results
Thirty-four patients with O-CSA and 61 with I-CSA were included in the analysis. The two groups were comparable with respect to age, body mass index (BMI), Epworth Sleepiness Scale, and burden of comorbidities. The mean daily equivalent dose of morphine in the O-CSA was 168 mg (range 30–1,217 mg). In the O-CSA group, 24 % of PAP-naïve patients responded to CPAP compared to 38 % in the I-CSA group. BiPAP and ASV were comparable in eliminating central events in both O-CSA (66 versus 60 %) and I-CSA (93 versus 90 %), respectively. Eight patients (24 %) with O-CSA and six patients (10 %) with I-CSA were considered nonresponders. The adherence rate was 48 and 24 % in the I-CSA group compared to 23 and 18 % in the O-CSA group at 3 and 12 months following initiation of effective treatment (p = 0.04 and p = 0.6).
Conclusions
The presence of O-CSA does not preclude an adequate response to CPAP. Adherence rate to PAP was poor in both the O-CSA and I-CSA groups. Further studies are needed to define optimal adherence rate and long-term benefits of PAP in CSA.
Similar content being viewed by others
References
(1997) The use of opioids for the treatment of chronic pain. A consensus statement from the American Academy of Pain Medicine and the American Pain Society. Clin J Pain 13(1):6–8
Colliver JD, Gfroerer JC (2008) Motive for nonmedical use of prescription pain relievers in the national survey on drug use and health. J Pain Off J Am Pain Soc 9(6):487–489, discussion 494–486
Trescot AM, Boswell MV, Atluri SL, Hansen HC, Deer TR, Abdi S, Jasper JF, Singh V, Jordan AE, Johnson BW, Cicala RS, Dunbar EE, Helm S 2nd, Varley KG, Suchdev PK, Swicegood JR, Calodney AK, Ogoke BA, Minore WS, Manchikanti L (2006) Opioid guidelines in the management of chronic non-cancer pain. Pain Physician 9(1):1–39
Manchikanti L (2006) Prescription drug abuse: what is being done to address this new drug epidemic? Testimony before the Subcommittee on Criminal Justice, Drug Policy and Human Resources. Pain Physician 9(4):287–321
Breivik H (2005) Opioids in chronic non-cancer pain, indications and controversies. Eur J Pain 9(2):127–130
Manchikanti L, Damron KS, McManus CD, Barnhill RC (2004) Patterns of illicit drug use and opioid abuse in patients with chronic pain at initial evaluation: a prospective, observational study. Pain Physician 7(4):431–437
Wang D, Teichtahl H, Drummer O, Goodman C, Cherry G, Cunnington D, Kronborg I (2005) Central sleep apnea in stable methadone maintenance treatment patients. Chest 128(3):1348–1356
Farney RJ, Walker JM, Cloward TV, Rhondeau S (2003) Sleep-disordered breathing associated with long-term opioid therapy. Chest 123(2):632–639
Teichtahl H, Wang D, Cunnington D, Quinnell T, Tran H, Kronborg I, Drummer OH (2005) Ventilatory responses to hypoxia and hypercapnia in stable methadone maintenance treatment patients. Chest 128(3):1339–1347
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (2013) Program THO. http://www.hopweb.org/hop/login.cfm. Accessed 7 May 2013
Kushida CA, Littner MR, Morgenthaler T, Alessi CA, Bailey D, Coleman J Jr, Friedman L, Hirshkowitz M, Kapen S, Kramer M, Lee-Chiong T, Loube DL, Owens J, Pancer JP, Wise M (2005) Practice parameters for the indications for polysomnography and related procedures: an update for 2005. Sleep 28(4):499–521
(1999) Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep 22(5):667–689
Issa FG, Sullivan CE (1986) Reversal of central sleep apnea using nasal CPAP. Chest 90(2):165–171
Hoffstein V, Slutsky AS (1987) Central sleep apnea reversed by continuous positive airway pressure. Am Rev Respir Dis 135(5):1210–1212
Aurora RN, Chowdhuri S, Ramar K, Bista SR, Casey KR, Lamm CI, Kristo DA, Mallea JM, Rowley JA, Zak RS, Tracy SL (2012) The treatment of central sleep apnea syndromes in adults: practice parameters with an evidence-based literature review and meta-analyses. Sleep 35(1):17–40
Badr MS, Toiber F, Skatrud JB, Dempsey J (1995) Pharyngeal narrowing/occlusion during central sleep apnea. J Appl Physiol 78(5):1806–1815
Edwards BA, Sands SA, Feeney C, Skuza EM, Brodecky V, Wilkinson MH, Berger PJ (2009) Continuous positive airway pressure reduces loop gain and resolves periodic central apneas in the lamb. Respir Physiol Neurobiol 168(3):239–249
Ramar K, Ramar P, Morgenthaler TI (2012) Adaptive servoventilation in patients with central or complex sleep apnea related to chronic opioid use and congestive heart failure. J Clin Sleep Med 8(5):569–576
Javaheri S, Malik A, Smith J, Chung E (2008) Adaptive pressure support servoventilation: a novel treatment for sleep apnea associated with use of opioids. J Clin Sleep Med 4(4):305–310
Farney RJ, Walker JM, Boyle KM, Cloward TV, Shilling KC (2008) Adaptive servoventilation (ASV) in patients with sleep disordered breathing associated with chronic opioid medications for non-malignant pain. J Clin Sleep Med 4(4):311–319
Chowdhuri S, Ghabsha A, Sinha P, Kadri M, Narula S, Badr MS (2012) Treatment of central sleep apnea in U.S. veterans. J Clin Sleep Med 8(5):555–563
Teschler H, Dohring J, Wang YM, Berthon-Jones M (2001) Adaptive pressure support servo-ventilation: a novel treatment for Cheyne-Stokes respiration in heart failure. Am J Respir Crit Care Med 164(4):614–619
Pepperell JC, Maskell NA, Jones DR, Langford-Wiley BA, Crosthwaite N, Stradling JR, Davies RJ (2003) A randomized controlled trial of adaptive ventilation for Cheyne-Stokes breathing in heart failure. Am J Respir Crit Care Med 168(9):1109–1114
Philippe C, Stoica-Herman M, Drouot X, Raffestin B, Escourrou P, Hittinger L, Michel PL, Rouault S, d’Ortho MP (2006) Compliance with and effectiveness of adaptive servoventilation versus continuous positive airway pressure in the treatment of Cheyne-Stokes respiration in heart failure over a six month period. Heart 92(3):337–342
Banno K, Okamura K, Kryger MH (2006) Adaptive servo-ventilation in patients with idiopathic Cheyne-Stokes breathing. J Clin Sleep Med 2(2):181–186
Alattar MA, Scharf SM (2009) Opioid-associated central sleep apnea: a case series. Sleep Breath 13(2):201–206
Guilleminault C, Cao M, Yue HJ, Chawla P (2010) Obstructive sleep apnea and chronic opioid use. Lung 188(6):459–468
Acknowledgments
This material is based upon work supported in part by the Department of Veterans Affairs and Clinical Sciences Research and Development. The contents of this manuscript do not represent the views of the Department of Veterans Affairs or the US Government.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Troitino, A., Labedi, N., Kufel, T. et al. Positive airway pressure therapy in patients with opioid-related central sleep apnea. Sleep Breath 18, 367–373 (2014). https://doi.org/10.1007/s11325-013-0894-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11325-013-0894-4